skip to main content

CLARITY trial - first participant; first infusion


We are proud to announce that we recruited our first participant to the CLARITY infusion trial!

The trial aims to text the efficacy of a new drug (BAN2401) on memory and cognition in people with Alzheimer's Disease and mild cognitive impairment (MMSE 22-30).

The first participant received their first infusion at Lymington hospital during the last week of November.

The MARC team would like to say a huge thank you to the team of nurses at Lymington (Jackie Hood, Kat Taylor, Mary Gough & Fawzia Rust) for their help and support during this collaboration.

Thank you also to everyone who has referred patients for this trial so far.

Do get in touch if you would like to learn more about this trial or potentially take part.

Page Comments